Abstract:Yan-Hua Chen, 1 Xue-Luo Zhang, 1 Zhong-Yun Li, 2 Xian-Ping Wang, 1 Jun Wang, 3 Zhi-Ping Zhang, 1 Peng-Fei Zhu, 1 Xue-Qing Wu 1 1 Reproductive Medicine Center, Shanxi Maternal and Child Health Care Hospital, Taiyuan, People's Republic of China; 2 Rectum Branch, Shanxi Provincial Hospital of Traditional Chinese Medicine, Taiyuan, People's Republic of China; 3 The Sixth Hospital of Shanxi Medical University (General Hospital of Tisco), Taiyuan, People's Republic of China Correspondence: Xue-Qing Wu, Reproductive Medicine Center, Shanxi Maternal and Child Health Care Hospital, No. 13, Xinmin Middle Street, Xinghualing District, Taiyuan, Shanxi Province, 030013, People's Republic of China, Tel +86 351-3360725, Email Objective: This study aimed to evaluate the therapeutic efficacy and safety of Dan'e Fukang soft extracts in moderate ovarian hyperstimulation syndrome (OHSS) for the simultaneous treatment of blood and fluid, guided by the traditional Chinese medicine principle of "triple prevention". Methods: This study conducted a retrospective analysis of clinical data from outpatients who underwent in vitro fertilization (IVF)/intracytoplasmic sperm injection embryo transfer (ICSI-ET). A total of 2245 cases were included and divided into a treatment group (1002 cases) and a control group (1243 cases). Patients in the treatment group were administered Dan'e Fukang soft extracts orally in addition to conventional Western medicine. Comparative assessments were made between the two groups on pelvic ascites volume, maximum ovary diameter, dysmenorrhea incidence post-oocyte retrieval, and safety indicators. Results: There were no statistically significant differences between the treatment group and the control group in terms of general characteristics or the levels of follicle-stimulating hormone (FSH), luteotropic hormone (LH), estradiol (E2), or progesterone (P) at the time of gonadotropin (Gn) initiation. The groups did not differ significantly when we compared the levels of LH, E2, or P on the day of human chorionic gonadotropin (hCG) injection and during ovarian hyperstimulation protocols ( P > 0.05 for all indicators). The differences in the volume of pelvic ascites, the maximum ovarian diameter, and the incidence of dysmenorrhea after oocyte retrieval were statistically significant between the treatment group and the control group ( P < 0.05 in both). There were no instances of adverse reactions in either group. Conclusion: Based on the traditional Chinese medicine principle of "triple prevention", the use of Dan'e Fukang soft extracts for the simultaneous treatment of blood and fluid in moderate OHSS significantly improved the absorption of pelvic ascites, promoted ovarian recovery, and reduced the incidence of dysmenorrhea after oocyte retrieval. Keywords: Dan'e Fukang soft extracts, guiding principle of triple prevention, in vitro fertilization embryo transfer/intracytoplasmic sperm injection embryo transfer, ovarian hyperstimulation syndrome, simultaneous treatment of blood and fluid Ovarian hyperstimulation syndrome (OHSS) is one of the main complications of artificial reproductive technology (ART) with in vitro fertilization embryo transfer (IVF-ET). 1 In clinic, based on the patient's past medical history, clinical manifestations, and additional examinations, OHSS is classified as mild, moderate, or severe. Previous epidemiological investigations have estimated the incidence of moderate and severe OHSS in patients receiving ART with IVF-ET at 3–6% and 0.1–2%, respectively, which leads to negative impact on the daily activities and work lives of patients to varying degrees. The pathogenesis and mechanism of OHSS is very complex. Previous studies have shown that an elevated transient receptor potential melastatin 2 (TRPM2) activity has been found in rat's OHSS-developed ovaries, 2 suggesting the important contributions of ion channels on the pathogenesis of OHSS. Besides, the increased secretions of some cytokines or mediators (eg including vascular endothelial growth factor [VEGF], platelet-derived growth [PDGF], insulin-like growth factor‐1 [IGF‐1]) also been demonstrated to occupy an important role in increased capillary permeability as well as the fluid accumulation in the third space, which may be responsible for the inflammatory response associated with follicular maturation, ovulation, corpus luteum function and embryo implantation. 3,4 Several strategies have been suggested to prevent or relieve the progression of OHSS according to the results obtained from clinical practice and experimental findings, for example, cycle cancel -Abstract Truncated-

Clinical value of Aescuven forte in preventing ovarian hyperstimulation syndrome

Effects of Gonadotropin-Releasing Hormone Antagonists on the Expression of Vascular Endothelial Growth Factor and Its Receptors in a Rat Model of Ovarian Hyperstimulation Syndrome.

Research on the Protocol of Limited Ovarian Stimulation to Prevent Ovarian Hyperstimulation Syndrome

The effect of elevated progesterone levels before oocyte retrieval in women undergoing ovarian stimulation for IVF treatment on the genomic profile of peri-implantation endometrium.

Voluven versus Calcium Gluconate for the prevention of ovarian hyperstimulation syndrome:a prospective, randomized controlled study

[Effect of Domestic Highly Purified Urinary Follicle Stimulating Hormone on Outcomes of in Vitro Fertilization-Embryo Transfer in Controlled Ovarian Stimulation].

[Application of Femoston in hormone replacement treatment-frozen embryo transfer and its clinical outcomes].

Can steroidal ovarian suppression during the luteal phase after oocyte retrieval reduce the risk of severe OHSS?

Application of oocytes in vitro maturation in preventing ovarian hyperstimulation syndrome.Jin Rentao

Comparison of Hydroxyethyle Starch Versus Human Albumin for Prevention of the Ovarian Hyperstimulation Syndrome

Efficacy of acupuncture for pregnancy with early-onset ovarian hyperstimulation syndrome: study protocol for a randomised controlled clinical trial

Effect of transdermal estrogen for luteal support in ovarian hypersensitivity patients undergoing IVF

Efficacy of Dan'e Fukang Soft Extract in Moderate Ovarian Hyperstimulation Syndrome for Concurrent Treatment of Blood and Fluid Guided by the "Triple Prevention" Principle

Clinical Analyses for 93 Cycles of Moderate and Severe Ovarian Hyperstimulation Syndrome

Pregnancy Outcome in Late-Onset Severe OHSS Patients Following Different Ascetic Fluid Drainage and Comparison with the Non-Ohss IVF Patients

Comparison of Bromocriptine and Hydroxyethyl Starch in the Prevention of Ovarian Hyperstimulation Syndrome

Electroacupuncture decreases the progression of ovarian hyperstimulation syndrome in a rat model

[Gonadotropin-Releasing Hormone Antagonist Protocol in Patients with Risk of Poor Response to Ovarian Stimulation in IVF-ET].

[Clinical Outcomes of Fresh Versus Cryopreserved-Thawed Embryo Transfer in High-Risk Patients with Ovarian Hyperstimulation Syndrome].

Pregnancy Outcomes in Patients with Late-Onset Severe OHSS Following Different Methods of Ascetic Fluid Drainage and a Comparison with Non-Ohss IVF Patients

Obstetric Outcome Analyses of 132 Cycles in Vitro Fertilized Pregnancies Complicated by Moderate and Severe Ovarian Hyperstimulation Syndrome